Form 4 for NHC NATIONAL HEALTHCARE CORP
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-02 · accession 0001437749-26-006645 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-03-02 | NHC | Flatt Stephen Fowler | CEO, Dir | M - OptEx | $90.62 | +5,000 | 67.2K | +8% | +$453.1K |
| D | 2026-03-03 | 2026-03-02 | NHC | Flatt Stephen Fowler | CEO, Dir | F - Tax | $171.15 | -3,585 | 63.7K | -5% | -$613.6K |
| D | 2026-03-03 | 2026-03-02 | NHC | Flatt Stephen Fowler | CEO, Dir | M - OptEx | $0.00 | -5,000 | 13.0K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | M | A | 5,000 | $90.62 | 67,237 | D | — | — | (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| 2 | Common | Common Stock | 2026-03-02 | F | D | 3,585 | $171.15 | 63,652 | D | — | — | (F2) Shares were withheld by the Company to pay tax obligations. (F3) Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. |
| 3 | Derivative | Option to Purchase Common Stock | 2026-03-02 | M | D | 5,000 | $0.00 | 13,000 | D | $90.62 · 2026-02-28 to 2030-02-28 | 18,000 Common Stock | (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |